Advertisement
Screener

ABSCI CORP (ABSI) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Absci Corp Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Absci Corp price/book ratio for the quarter ending 2026-06-30 was 7.34, a 288.84% increase year-over-year.
  • Absci Corp price/book ratio for the quarter ending 2026-03-31 was 2.67, a 66.04% increase year-over-year.
  • Absci Corp price/book ratio for the quarter ending 2025-12-31 was 2.77, a 63.94% increase year-over-year.
  • Absci Corp price/book ratio for the quarter ending 2025-09-30 was 2.17, a 0.07% increase year-over-year.
  • Absci Corp price/book ratio for fiscal 2026 was 7.34.
  • Absci Corp price/book ratio for fiscal 2025 was 2.77, a 63.94% increase from fiscal 2024.
  • Absci Corp price/book ratio for fiscal 2024 was 1.69, a 23.97% decline from fiscal 2023.
  • Absci Corp price/book ratio for fiscal 2023 was 2.22, a 213.80% increase from fiscal 2022.
Available history
2021-09-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-307.34$1.81B$246.13M
2026-03-312.67$459.06M$171.97M
2025-12-312.77$524.04M$189.45M
2025-09-302.17$456.04M$210.34M
2025-06-301.89$327.19M$173.37M
2025-03-311.61$319.61M$198.8M
2024-12-311.69$302.25M$179.13M
2024-09-302.17$436.21M$201.34M
2024-06-301.58$349.41M$221.49M
2024-03-312.67$641.83M$240.11M
2023-12-312.22$390.97M$176.18M
2023-09-300.62$122.68M$196.42M
2023-06-300.65$140.74M$215.4M
2023-03-310.64$161.84M$253.97M
2022-12-310.71$194.06M$274.41M
2022-09-300.99$290.73M$292.94M
2022-06-300.97$308.03M$316.19M
2022-03-312.3$782.6M$340.5M
2021-12-312.08$759.71M$366.11M
2021-09-302.77$1.08B$388.01M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-307.34$1.81B$246.13M
2025-12-312.77$524.04M$189.45M
2024-12-311.69$302.25M$179.13M
2023-12-312.22$390.97M$176.18M
2022-12-310.71$194.06M$274.41M
2021-12-312.08$759.71M$366.11M

Similar stocks

Stock NameCountryMarket CapPE Ratio
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14